Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 437

1.

The Effect of 13-Valent Pneumococcal Conjugate Vaccine on the Serotype Distribution and Antibiotic Resistance Profiles in Children With Invasive Pneumococcal Disease.

Gaviria-Agudelo CL, Jordan-Villegas A, Garcia C, McCracken GH Jr.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):253-259. doi: 10.1093/jpids/piw005.

PMID:
26907814
2.

Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Clin Infect Dis. 2011 Oct;53(7):617-30. doi: 10.1093/cid/cir625.

3.

The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Bradley JS, Byington CL, Shah SS, Alverson B, Carter ER, Harrison C, Kaplan SL, Mace SE, McCracken GH Jr, Moore MR, St Peter SD, Stockwell JA, Swanson JT; Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.

Clin Infect Dis. 2011 Oct;53(7):e25-76. doi: 10.1093/cid/cir531. Epub 2011 Aug 31.

PMID:
21880587
4.

Pharmacokinetics of oseltamivir according to trimester of pregnancy.

Greer LG, Leff RD, Rogers VL, Roberts SW, McCracken GH Jr, Wendel GD Jr, Sheffield JS.

Am J Obstet Gynecol. 2011 Jun;204(6 Suppl 1):S89-93. doi: 10.1016/j.ajog.2011.03.005. Epub 2011 Mar 9.

5.

Pharmacokinetics of oseltamivir in breast milk and maternal plasma.

Greer LG, Leff RD, Rogers VL, Roberts SW, McCracken GH Jr, Wendel GD Jr, Sheffield JS.

Am J Obstet Gynecol. 2011 Jun;204(6):524.e1-4. doi: 10.1016/j.ajog.2011.01.056. Epub 2011 Mar 31.

6.

Viral coinfections in children with invasive pneumococcal disease.

Techasaensiri B, Techasaensiri C, Mejías A, McCracken GH Jr, Ramilo O.

Pediatr Infect Dis J. 2010 Jun;29(6):519-23. doi: 10.1097/INF.0b013e3181cdafc2.

PMID:
20051928
7.

Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunization in Dallas, Texas.

Techasaensiri C, Messina AF, Katz K, Ahmad N, Huang R, McCracken GH Jr.

Pediatr Infect Dis J. 2010 Apr;29(4):294-300. doi: 10.1097/INF.0b013e3181c2a229.

PMID:
19949357
8.

The antibiotic pipeline in pediatrics.

McCracken GH.

Adv Exp Med Biol. 2009;634:147-51. No abstract available.

PMID:
19280856
9.

The pediatric infectious disease journal(r) newsletter: march 2009.

Nelson JD, McCracken GH Jr.

Pediatr Infect Dis J. 2009 Mar;28(3):A5-6. doi: 10.1097/01.inf.0000347256.78822.c5. No abstract available.

PMID:
19252427
10.

Tigecycline therapy significantly reduces the concentrations of inflammatory pulmonary cytokines and chemokines in a murine model of Mycoplasma pneumoniae pneumonia.

Salvatore CM, Techasaensiri C, Tagliabue C, Katz K, Leos N, Gomez AM, McCracken GH, Hardy RD.

Antimicrob Agents Chemother. 2009 Apr;53(4):1546-51. doi: 10.1128/AAC.00979-08. Epub 2009 Jan 12.

11.

Pharmacokinetics and pharmacodynamics of linezolid in children with cystic fibrosis.

Santos RP, Prestidge CB, Brown ME, Urbancyzk B, Murphey DK, Salvatore CM, Jafri HS, McCracken GH Jr, Ahmad N, Sanchez PJ, Siegel JD.

Pediatr Pulmonol. 2009 Feb;44(2):148-54. doi: 10.1002/ppul.20966.

PMID:
19137597
12.

Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia.

Bradley JS, McCracken GH.

Clin Infect Dis. 2008 Dec 1;47 Suppl 3:S241-8. doi: 10.1086/591410. Review.

PMID:
18986297
13.

Daptomycin therapy for invasive Gram-positive bacterial infections in children.

Ardura MI, Mejías A, Katz KS, Revell P, McCracken GH Jr, Sánchez PJ.

Pediatr Infect Dis J. 2007 Dec;26(12):1128-32.

PMID:
18043450
14.

Glycerol and bacterial meningitis.

Sáez-Llorens X, McCracken GH Jr.

Clin Infect Dis. 2007 Nov 15;45(10):1287-9. Epub 2007 Oct 15. No abstract available.

PMID:
17968822
15.

Systemic cytokine profile in children with community-acquired pneumonia.

Michelow IC, Katz K, McCracken GH, Hardy RD.

Pediatr Pulmonol. 2007 Jul;42(7):640-5.

PMID:
17534977
16.

Impact of the pneumococcal conjugate vaccine on serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Dallas, TX, children from 1999 through 2005.

Messina AF, Katz-Gaynor K, Barton T, Ahmad N, Ghaffar F, Rasko D, McCracken GH Jr.

Pediatr Infect Dis J. 2007 Jun;26(6):461-7.

PMID:
17529859
17.

Respiratory tract infection with Mycoplasma pneumoniae in interleukin-12 knockout mice results in improved bacterial clearance and reduced pulmonary inflammation.

Salvatore CM, Fonseca-Aten M, Katz-Gaynor K, Gomez AM, Mejias A, Somers C, Chavez-Bueno S, McCracken GH, Hardy RD.

Infect Immun. 2007 Jan;75(1):236-42. Epub 2006 Oct 30.

18.

Effect of clarithromycin on cytokines and chemokines in children with an acute exacerbation of recurrent wheezing: a double-blind, randomized, placebo-controlled trial.

Fonseca-Aten M, Okada PJ, Bowlware KL, Chavez-Bueno S, Mejias A, Rios AM, Katz K, Olsen K, Ng S, Jafri HS, McCracken GH, Ramilo O, Hardy RD.

Ann Allergy Asthma Immunol. 2006 Oct;97(4):457-63.

PMID:
17069099
19.

Treatment of experimental chronic pulmonary mycoplasmosis.

Fonseca-Aten M, Rios AM, Mejias A, Chavez-Bueno S, Katz K, Gomez AM, Ramilo O, McCracken GH, Hardy RD.

Int J Antimicrob Agents. 2006 Sep;28(3):253-8. Epub 2006 Aug 7.

PMID:
16891098
20.

Cefdinir pharmacokinetics and tolerability in children receiving 25 mg/kg once daily.

Bowlware KL, McCracken GH Jr, Lozano-Hernandez J, Ghaffar F.

Pediatr Infect Dis J. 2006 Mar;25(3):208-10.

PMID:
16511381
21.

Evidence behind the WHO guidelines: hospital care for children.

Ryan M, McCracken GH Jr; WHO.

J Trop Pediatr. 2006 Feb;52(1):46-8. Review. No abstract available.

PMID:
16436544
22.

A historical perspective on pharmacological studies of gentamicin for therapy of neonatal meningitis.

McCracken GH Jr.

J Pediatr Pharmacol Ther. 2006 Jan;11(1):4-9. doi: 10.5863/1551-6776-11.1.4. No abstract available.

23.

Evaluation of LBM415 (NVP PDF-713), a novel peptide deformylase inhibitor, for treatment of experimental Mycoplasma pneumoniae pneumonia.

Fonseca-Aten M, Salvatore CM, Mejías A, Ríos AM, Chávez-Bueno S, Katz K, Gómez AM, McCracken GH Jr, Hardy RD.

Antimicrob Agents Chemother. 2005 Oct;49(10):4128-36.

24.

Microbiologic and immunologic evaluation of a single high dose of azithromycin for treatment of experimental Mycoplasma pneumoniae pneumonia.

Ríos AM, Fonseca-Aten M, Mejías A, Chávez-Bueno S, Katz K, Gómez AM, McCracken GH Jr, Ramilo O, Hardy RD.

Antimicrob Agents Chemother. 2005 Sep;49(9):3970-3.

25.

Bacterial meningitis in children.

Chávez-Bueno S, McCracken GH Jr.

Pediatr Clin North Am. 2005 Jun;52(3):795-810, vii. Review.

PMID:
15925663
26.

Inducible clindamycin resistance and molecular epidemiologic trends of pediatric community-acquired methicillin-resistant Staphylococcus aureus in Dallas, Texas.

Chavez-Bueno S, Bozdogan B, Katz K, Bowlware KL, Cushion N, Cavuoti D, Ahmad N, McCracken GH Jr, Appelbaum PC.

Antimicrob Agents Chemother. 2005 Jun;49(6):2283-8.

27.

Mycoplasma pneumoniae induces host-dependent pulmonary inflammation and airway obstruction in mice.

Fonseca-Aten M, Ríos AM, Mejías A, Chávez-Bueno S, Katz K, Gómez AM, McCracken GH Jr, Hardy RD.

Am J Respir Cell Mol Biol. 2005 Mar;32(3):201-10. Epub 2004 Dec 30.

PMID:
15626776
28.

Effect of the 7-valent pneumococcal conjugate vaccine on nasopharyngeal colonization by Streptococcus pneumoniae in the first 2 years of life.

Ghaffar F, Barton T, Lozano J, Muniz LS, Hicks P, Gan V, Ahmad N, McCracken GH Jr.

Clin Infect Dis. 2004 Oct 1;39(7):930-8. Epub 2004 Sep 13.

PMID:
15472842
29.

Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.

Ríos AM, Mejías A, Chávez-Bueno S, Fonseca-Aten M, Katz K, Hatfield J, Gómez AM, Jafri HS, McCracken GH Jr, Ramilo O, Hardy RD.

Antimicrob Agents Chemother. 2004 Aug;48(8):2897-904.

30.

Current management of bacterial meningitis.

McCracken GH Jr.

Adv Exp Med Biol. 2004;549:31-3. Review. No abstract available.

PMID:
15250513
32.

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children.

Michelow IC, Olsen K, Lozano J, Rollins NK, Duffy LB, Ziegler T, Kauppila J, Leinonen M, McCracken GH Jr.

Pediatrics. 2004 Apr;113(4):701-7.

PMID:
15060215
33.

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus.

Lee MC, Rios AM, Aten MF, Mejias A, Cavuoti D, McCracken GH Jr, Hardy RD.

Pediatr Infect Dis J. 2004 Feb;23(2):123-7.

PMID:
14872177
34.

Factors influencing the anti-inflammatory effect of dexamethasone therapy in experimental pneumococcal meningitis.

Lutsar I, Friedland IR, Jafri HS, Wubbel L, Ahmed A, Trujillo M, McCoig CC, McCracken GH Jr.

J Antimicrob Chemother. 2003 Oct;52(4):651-5. Epub 2003 Sep 1.

PMID:
12951330
35.

Bacterial meningitis in children.

Sáez-Llorens X, McCracken GH Jr.

Lancet. 2003 Jun 21;361(9375):2139-48. Review.

PMID:
12826449
36.

Antimicrobial and immunologic activities of clarithromycin in a murine model of Mycoplasma pneumoniae-induced pneumonia.

Hardy RD, Rios AM, Chavez-Bueno S, Jafri HS, Hatfield J, Rogers BB, McCracken GH, Ramilo O.

Antimicrob Agents Chemother. 2003 May;47(5):1614-20.

37.

Garenoxacin (BMS-284756) and moxifloxacin in experimental meningitis caused by vancomycin-tolerant pneumococci.

Rodriguez-Cerrato V, McCoig CC, Saavedra J, Barton T, Michelow IC, Hardy RD, Bowlware K, Iglehart J, Katz K, McCracken GH Jr.

Antimicrob Agents Chemother. 2003 Jan;47(1):211-5.

38.

Flaws in design and conduct of clinical trials in acute otitis media.

Dagan R, McCracken GH Jr.

Pediatr Infect Dis J. 2002 Oct;21(10):894-902. Review. No abstract available.

PMID:
12394809
39.

Rich nations, poor nations, and bacterial meningitis.

McCracken GH Jr.

Lancet. 2002 Jul 20;360(9328):183. No abstract available.

PMID:
12133648
41.

Diagnosis and management of acute otitis media in the urgent care setting.

McCracken GH Jr.

Ann Emerg Med. 2002 Apr;39(4):413-21. Review.

PMID:
11919528
42.

Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease.

Hardy RD, Jafri HS, Olsen K, Hatfield J, Iglehart J, Rogers BB, Patel P, Cassell G, McCracken GH, Ramilo O.

Infect Immun. 2002 Feb;70(2):649-54.

43.

Quinolone treatment for pediatric bacterial meningitis: a comparative study of trovafloxacin and ceftriaxone with or without vancomycin.

Sáez-Llorens X, McCoig C, Feris JM, Vargas SL, Klugman KP, Hussey GD, Frenck RW, Falleiros-Carvalho LH, Arguedas AG, Bradley J, Arrieta AC, Wald ER, Pancorbo S, McCracken GH Jr, Marques SR; Trovan menigitis Study Group.

Pediatr Infect Dis J. 2002 Jan;21(1):14-22. Erratum in: Pediatr Infect Dis J 2002 Mar;21(3):270.

PMID:
11791092
44.

Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection.

Michelow IC, Lozano J, Olsen K, Goto C, Rollins NK, Ghaffar F, Rodriguez-Cerrato V, Leinonen M, McCracken GH Jr.

Clin Infect Dis. 2002 Jan 1;34(1):E1-11. Epub 2001 Nov 27.

PMID:
11731965
45.

BMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.

Rodriguez-Cerrato V, Ghaffar F, Saavedra J, Michelow IC, Hardy RD, Iglehart J, Olsen K, McCracken GH Jr.

Antimicrob Agents Chemother. 2001 Nov;45(11):3098-103.

46.

Pharmacodynamics and bactericidal activity of moxifloxacin in experimental Escherichia coli meningitis.

Rodriguez-Cerrato V, McCoig CC, Michelow IC, Ghaffar F, Jafri HS, Hardy RD, Patel C, Olsen K, McCracken GH Jr.

Antimicrob Agents Chemother. 2001 Nov;45(11):3092-7.

47.

Clinical practice guidelines for the diagnosis and treatment of respiratory tract infections.

McCracken GH Jr.

Am J Manag Care. 2001 Jun;7(6 Suppl):S183-91. Review.

48.

Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile.

Hardy RD, Jafri HS, Olsen K, Wordemann M, Hatfield J, Rogers BB, Patel P, Duffy L, Cassell G, McCracken GH, Ramilo O.

Infect Immun. 2001 Jun;69(6):3869-76.

49.

Acute mastoiditis in children: a seventeen-year experience in Dallas, Texas.

Ghaffar FA, Wördemann M, McCracken GH Jr.

Pediatr Infect Dis J. 2001 Apr;20(4):376-80.

PMID:
11332661
50.

Comparative study of cefepime versus ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia.

Mustafa MM, Carlson L, Tkaczewski I, McCracken GH Jr, Buchanan GR.

Pediatr Infect Dis J. 2001 Mar;20(3):362-9. Review.

PMID:
11303851

Supplemental Content

Loading ...
Support Center